Literature DB >> 10666535

Differences in somatic perception in female patients with irritable bowel syndrome with and without fibromyalgia.

L Chang1, E A Mayer, T Johnson, L Z FitzGerald, B Naliboff.   

Abstract

BACKGROUND: Irritable bowel syndrome (IBS) and fibromyalgia (FM) are considered chronic syndromes of altered visceral and somatic perception, respectively. Because there is a significant overlap of IBS and FM, shared pathophysiological mechanisms have been suggested. Although visceral perception has been well studied in IBS, somatic perception has not. AIMS: To compare hypervigilance and altered sensory perception in response to somatic stimuli in patients with IBS, IBS+FM, and healthy controls.
METHODS: Eleven IBS females (mean age 40), 11 IBS+FM females (mean age 46), and ten healthy female controls (mean age 39) rated pain perception in response to pressure stimuli administered to active somatic tender points, non-tender control points and the T-12 dermatome, delivered in a predictable ascending series, and delivered in an unpredictable randomized fashion (fixed stimulus).
RESULTS: Although IBS patients had similar pain thresholds during the ascending series compared with controls, they were found to have somatic hypoalgesia with higher pain thresholds and lower pain frequency and severity during fixed stimulus series compared with IBS+FM patients and controls (P<0.05). Patients with IBS+FM were more bothered by the somatic stimuli and had somatic hyperalgesia with lower pain thresholds and higher pain frequency and severity.
CONCLUSIONS: Both hypervigilance and somatic hypoalgesia contribute to the altered somatic perception in IBS patients. Co-morbidity with FM results in somatic hyperalgesia in IBS patients.

Entities:  

Mesh:

Year:  2000        PMID: 10666535     DOI: 10.1016/s0304-3959(99)00215-8

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  49 in total

Review 1.  New insights into visceral hypersensitivity--clinical implications in IBS.

Authors:  QiQi Zhou; G Nicholas Verne
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-06       Impact factor: 46.802

Review 2.  Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms?

Authors:  S E Kim; L Chang
Journal:  Neurogastroenterol Motil       Date:  2012-08-02       Impact factor: 3.598

3.  Anticipation of public speaking and sleep and the hypothalamic-pituitary-adrenal axis in women with irritable bowel syndrome.

Authors:  M M Heitkemper; K C Cain; W Deechakawan; A Poppe; S-E Jun; R L Burr; M E Jarrett
Journal:  Neurogastroenterol Motil       Date:  2012-04-03       Impact factor: 3.598

Review 4.  [Psychophysiology of visceral pain].

Authors:  B Horing; P Enck
Journal:  Schmerz       Date:  2014-06       Impact factor: 1.107

Review 5.  Irritable bowel syndrome as a common precipitant of central sensitization.

Authors:  G Nicholas Verne; Donald D Price
Journal:  Curr Rheumatol Rep       Date:  2002-08       Impact factor: 4.592

Review 6.  Medical and psychological risks and consequences of long-term opioid therapy in women.

Authors:  Beth D Darnall; Brett R Stacey; Roger Chou
Journal:  Pain Med       Date:  2012-08-20       Impact factor: 3.750

7.  Development and validation of new disease-specific measures of somatization and comorbidity in IBS.

Authors:  Elizabeth W MacLean; Olafur S Palsson; Marsha J Turner; William E Whitehead
Journal:  J Psychosom Res       Date:  2012-08-31       Impact factor: 3.006

Review 8.  Current insights into the pathophysiology of irritable bowel syndrome.

Authors:  Ines Schwetz; Sylvie Bradesi; Emeran A Mayer
Journal:  Curr Gastroenterol Rep       Date:  2003-08

9.  Increased startle responses in interstitial cystitis: evidence for central hyperresponsiveness to visceral related threat.

Authors:  Christian Twiss; Lisa Kilpatrick; Michelle Craske; C A Tony Buffington; Edward Ornitz; Larissa V Rodríguez; Emeran A Mayer; Bruce D Naliboff
Journal:  J Urol       Date:  2009-03-14       Impact factor: 7.450

10.  Central and peripheral hypersensitivity in the irritable bowel syndrome.

Authors:  QiQi Zhou; Roger B Fillingim; Joseph L Riley; William B Malarkey; G Nicholas Verne
Journal:  Pain       Date:  2010-01-13       Impact factor: 6.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.